{"entity":{"type":"insider","cik":"0001652824","url":"/insider/0001652824","json_url":"/insider/0001652824.json","name":"Mills Kenneth T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":109,"n_filings":53,"first":"2017-04-26","last":"2025-05-14","span_basis":"filed_date"},"name_variants":[{"name":"Mills Kenneth T.","source":"filing","n_filings":53,"first_seen":"2017-04-26","last_seen":"2025-05-14"}],"transactions":[{"id":4895082,"accession":"0001562180-25-003822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003822","line_url":"/filing/0001562180-25-003822#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20602.0,"shares_display":"20,602","price_per_share":7.9141,"price_display":"7.91","price_state":"stated","total_value":163046.2882,"total_display":"163,046.29","total_whole":"163,046","shares_owned_after":475103.0,"shares_owned_after_display":"475,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":2560742,"accession":"0001562180-24-005855","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-005855","line_url":"/filing/0001562180-24-005855#line-4","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15369.0,"shares_display":"15,369","price_per_share":13.9567,"price_display":"13.96","price_state":"stated","total_value":214500.5223,"total_display":"214,500.52","total_whole":"214,501","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-26","scope":"insider"},{"id":2560724,"accession":"0001562180-24-005855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-005855","line_url":"/filing/0001562180-24-005855#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12221.0,"shares_display":"12,221","price_per_share":13.7823,"price_display":"13.78","price_state":"stated","total_value":168433.4883,"total_display":"168,433.49","total_whole":"168,433","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":3050331,"accession":"0001562180-24-005798","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-005798","line_url":"/filing/0001562180-24-005798#line-4","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2210.0,"shares_display":"2,210","price_per_share":13.7737,"price_display":"13.77","price_state":"stated","total_value":30439.877,"total_display":"30,439.88","total_whole":"30,440","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-18","scope":"insider"},{"id":3050320,"accession":"0001562180-24-005798","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-005798","line_url":"/filing/0001562180-24-005798#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":13.76,"price_display":"13.76","price_state":"stated","total_value":2752.0,"total_display":"2,752.00","total_whole":"2,752","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider"},{"id":2056759,"accession":"0001562180-24-004104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-004104","line_url":"/filing/0001562180-24-004104#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.8148,"price_display":"15.81","price_state":"stated","total_value":237222.0,"total_display":"237,222.00","total_whole":"237,222","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2868670,"accession":"0001562180-24-003452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-003452","line_url":"/filing/0001562180-24-003452#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.1914,"price_display":"18.19","price_state":"stated","total_value":272871.0,"total_display":"272,871.00","total_whole":"272,871","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-17","scope":"insider"},{"id":2560031,"accession":"0001562180-24-002771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-002771","line_url":"/filing/0001562180-24-002771#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":21.8628,"price_display":"21.86","price_state":"stated","total_value":327942.0,"total_display":"327,942.00","total_whole":"327,942","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider"},{"id":2253009,"accession":"0001562180-24-001395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-001395","line_url":"/filing/0001562180-24-001395","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.75658392,"price_display":"16.76","price_state":"stated","total_value":251348.7588,"total_display":"251,348.76","total_whole":"251,349","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-16","scope":"insider","n_lines":2},{"id":3207005,"accession":"0001562180-24-000544","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-000544","line_url":"/filing/0001562180-24-000544#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":15.1776,"price_display":"15.18","price_state":"stated","total_value":682992.0,"total_display":"682,992.00","total_whole":"682,992","shares_owned_after":408035.0,"shares_owned_after_display":"408,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8211265,"accession":"0001562180-23-008519","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-008519","line_url":"/filing/0001562180-23-008519#line-3","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":19.685,"price_display":"19.68","price_state":"stated","total_value":885825.0,"total_display":"885,825.00","total_whole":"885,825","shares_owned_after":355289.0,"shares_owned_after_display":"355,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-21","scope":"insider"},{"id":5436658,"accession":"0001562180-21-006967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-006967","line_url":"/filing/0001562180-21-006967#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-10","scope":"insider"},{"id":5376567,"accession":"0001562180-21-006147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-006147","line_url":"/filing/0001562180-21-006147#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":42.19,"price_display":"42.19","price_state":"stated","total_value":63285.0,"total_display":"63,285.00","total_whole":"63,285","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-29","scope":"insider"},{"id":4383397,"accession":"0001562180-21-005947","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-21-005947","line_url":"/filing/0001562180-21-005947#line-5","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":45.11,"price_display":"45.11","price_state":"stated","total_value":1578850.0,"total_display":"1,578,850.00","total_whole":"1,578,850","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":4383384,"accession":"0001562180-21-005947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-005947","line_url":"/filing/0001562180-21-005947#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":120060.0,"total_display":"120,060.00","total_whole":"120,060","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4185920,"accession":"0001562180-21-004525","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-004525","line_url":"/filing/0001562180-21-004525#line-4","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":40.25,"price_display":"40.25","price_state":"stated","total_value":60375.0,"total_display":"60,375.00","total_whole":"60,375","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-28","scope":"insider"},{"id":4185914,"accession":"0001562180-21-004525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-004525","line_url":"/filing/0001562180-21-004525#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":180090.0,"total_display":"180,090.00","total_whole":"180,090","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-28","scope":"insider"},{"id":4234390,"accession":"0001562180-21-001682","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-001682","line_url":"/filing/0001562180-21-001682#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":40.77,"price_display":"40.77","price_state":"stated","total_value":61155.0,"total_display":"61,155.00","total_whole":"61,155","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-03-01","scope":"insider"},{"id":4145187,"accession":"0001562180-21-000562","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-000562","line_url":"/filing/0001562180-21-000562","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":44.73526,"price_display":"44.74","price_state":"stated","total_value":290779.19,"total_display":"290,779.19","total_whole":"290,779","shares_owned_after":280984.0,"shares_owned_after_display":"280,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":3},{"id":5224994,"accession":"0001562180-21-000282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-000282","line_url":"/filing/0001562180-21-000282#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":75015.0,"total_display":"75,015.00","total_whole":"75,015","shares_owned_after":281984.0,"shares_owned_after_display":"281,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-11","scope":"insider"},{"id":3271891,"accession":"0001562180-20-007506","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-007506","line_url":"/filing/0001562180-20-007506","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":48.66670307692308,"price_display":"48.67","price_state":"stated","total_value":316333.57,"total_display":"316,333.57","total_whole":"316,334","shares_owned_after":242853.0,"shares_owned_after_display":"242,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-30","scope":"insider","n_lines":2},{"id":3190786,"accession":"0001562180-20-007469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-007469","line_url":"/filing/0001562180-20-007469#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":241000.0,"shares_owned_after_display":"241,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider"},{"id":3069206,"accession":"0001562180-20-007351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-007351","line_url":"/filing/0001562180-20-007351#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":675000.0,"total_display":"675,000.00","total_whole":"675,000","shares_owned_after":241000.0,"shares_owned_after_display":"241,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider"},{"id":3150343,"accession":"0001562180-20-007249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-007249","line_url":"/filing/0001562180-20-007249#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":241000.0,"shares_owned_after_display":"241,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider"},{"id":8630383,"accession":"0001562180-19-004927","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-004927","line_url":"/filing/0001562180-19-004927","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":39.749656,"price_display":"39.75","price_state":"stated","total_value":397496.56,"total_display":"397,496.56","total_whole":"397,497","shares_owned_after":241000.0,"shares_owned_after_display":"241,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-19","filed_date":"2019-09-23","scope":"insider","n_lines":2},{"id":8630344,"accession":"0001562180-19-004433","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-004433","line_url":"/filing/0001562180-19-004433","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":37.549525333333335,"price_display":"37.55","price_state":"stated","total_value":563242.88,"total_display":"563,242.88","total_whole":"563,243","shares_owned_after":246376.0,"shares_owned_after_display":"246,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider","n_lines":2},{"id":8041918,"accession":"0001562180-19-004035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-004035","line_url":"/filing/0001562180-19-004035","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":49.4874,"price_display":"49.49","price_state":"stated","total_value":742311.0,"total_display":"742,311.00","total_whole":"742,311","shares_owned_after":248300.0,"shares_owned_after_display":"248,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-19","filed_date":"2019-07-23","scope":"insider","n_lines":2},{"id":8017479,"accession":"0001562180-19-003604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-003604","line_url":"/filing/0001562180-19-003604","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":52.53917333333333,"price_display":"52.54","price_state":"stated","total_value":788087.6,"total_display":"788,087.60","total_whole":"788,088","shares_owned_after":250120.0,"shares_owned_after_display":"250,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-21","scope":"insider","n_lines":2},{"id":8081616,"accession":"0001562180-19-003056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-19-003056","line_url":"/filing/0001562180-19-003056","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":42.99107733333334,"price_display":"42.99","price_state":"stated","total_value":644866.16,"total_display":"644,866.16","total_whole":"644,866","shares_owned_after":246300.0,"shares_owned_after_display":"246,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider","n_lines":3},{"id":8307704,"accession":"0001562180-19-002331","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-19-002331","line_url":"/filing/0001562180-19-002331","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":50.43774533333333,"price_display":"50.44","price_state":"stated","total_value":756566.18,"total_display":"756,566.18","total_whole":"756,566","shares_owned_after":250670.0,"shares_owned_after_display":"250,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-22","filed_date":"2019-04-24","scope":"insider","n_lines":5},{"id":8179585,"accession":"0001562180-19-002005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-002005","line_url":"/filing/0001562180-19-002005","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":58.53259333333333,"price_display":"58.53","price_state":"stated","total_value":877988.9,"total_display":"877,988.90","total_whole":"877,989","shares_owned_after":246000.0,"shares_owned_after_display":"246,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider","n_lines":2},{"id":8609158,"accession":"0001562180-19-001047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-19-001047","line_url":"/filing/0001562180-19-001047","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":47.285570666666665,"price_display":"47.29","price_state":"stated","total_value":709283.56,"total_display":"709,283.56","total_whole":"709,284","shares_owned_after":246000.0,"shares_owned_after_display":"246,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-19","scope":"insider","n_lines":3},{"id":8228336,"accession":"0001562180-19-000337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-000337","line_url":"/filing/0001562180-19-000337#line-2","is_derivative":false,"issuer_cik":"0001590877","issuer_name":"REGENXBIO Inc.","issuer_ticker":"RGNX","issuer_name_source":null,"issuer_url":"/issuer/0001590877","owner_cik":"0001652824","owner_name":"Mills Kenneth T.","owner_display_name":"Mills Kenneth T.","owner_url":"/insider/0001652824","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11860.0,"shares_display":"11,860","price_per_share":43.7,"price_display":"43.70","price_state":"stated","total_value":518282.0,"total_display":"518,282.00","total_whole":"518,282","shares_owned_after":204140.0,"shares_owned_after_display":"204,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-15","filed_date":"2019-01-17","scope":"insider"}],"collapsed":true,"next_cursor":"2019-01-15|8228336","ledger_fault":false,"count":{"value":109,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":109,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":109},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001590877","name":"REGENXBIO Inc.","url":"/issuer/0001590877","role":"Director, Officer (President and CEO)","n_filings":53,"first_seen":"2017-04-26","last_seen":"2025-05-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652824","retrieved_at":"2026-08-24T21:59:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}